Nifty
Sensex
:
:
11661.85
39298.38
75.50 (0.65%)
246.32 (0.63%)

Pharmaceuticals & Drugs

Rating :
74/99

BSE: 506260 | NSE: Not Listed

138.90
18-Oct-2019
  • Open
  • High
  • Low
  • Previous Close
  •  140.85
  •  141.00
  •  138.65
  •  138.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  36
  •  2.22
  •  173.00
  •  101.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 348.03
  • 14.78
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 340.93
  • 1.98%
  • 2.04

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.04%
  • 0.00%
  • 25.66%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.30%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.90
  • 2.48
  • 15.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.65
  • -0.70
  • 5.72

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.41
  • 1.22
  • 5.24

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.35
  • 22.34
  • 21.91

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.92
  • 3.76
  • 2.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.82
  • 14.26
  • 14.07

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Anuh Pharma gets EuGMP Certificate from Spanish Health Authority for five products
    1st Oct 2019, 11:36 AM

    The products are Erythromycin, Erythromycin Ethyl Succinate, Pyrazinamide, Sulfadoxine and Pyrimethamine

    Read More
  • USFDA completes inspection at Anuh Pharma’s facility
    20th Sep 2019, 11:05 AM

    The facility was inspected by USFDA from September 16, 2019 to September 20, 2019

    Read More
  • Anuh Pharma - Quarterly Results
    7th Aug 2019, 16:15 PM

    Read More
  • Anuh Pharma receives approval from WHO-Geneva Prequalification
    5th Aug 2019, 11:47 AM

    The Prequalification Inspection Group has recommended that the API's Pyrimethamine, Pyrazinamide and Sulfadoxine can be considered to be compliant

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.